Ozell joined atai Life Sciences in July 2021. He is responsible for directing and managing activities for the contracts administration function for atai and its platform companies.
Drawing on over 20 years of experience in research and drug development, Ozell most recently spent five years as a Biotech Consultant through the company he founded, HMTP Biotech Support Services, providing consulting services to multiple biotech and life sciences companies including Shoreline Biosciences, Travere Therapeutics, Ferring Research Institute, Harrow Health, and Imprimis Pharmaceuticals. Prior to that, he held various operational and strategic roles in legal and R&D for Regulus Therapeutics, ACADIA Pharmaceuticals, the Sanford Burnham Prebys Medical Discovery Institute, the University of California San Diego, and the University of Michigan.
Ozell spent 18 years in San Diego, California, following undergraduate studies at the University of Michigan, before relocating to Berlin in 2020.